Peter A. Parks
Psychiatric in Topeka, KS

6726624, Apr 27, 2004

Mar 6, 2002

10/092284

Richard S. Keirsbilck - Rochester NY
Peter A. Parks - Topeka KS
David L. Patton - Webster NY
Richard N. Blazey - Penfield NY
Paige Miller - Rochester NY

The McLean Hospital Corporation - Belmont MA

A61B 500

600300, 600549

A method for determining the appropriate dosage of a medication to treat Attention Deficit Hyperactivity Disorder (ADHD) in an individual who has ADHD. The method comprises sampling the peripheral skin temperature of left and right like extremities of an individual during a predetermined time interval when the individual is in a sensory deprived state to provide respective left and right sampled peripheral skin temperature data; processing the sampled peripheral skin temperature data; processing the sampled peripheral skin temperature data including filtering, differentiation, and conversion to the frequency domain to derive spectral signatures whose magnitudes are indicative of the level of ADHD manifestation. The effectiveness of the medication is calculated by comparison to predetermined threshold values.

6746409, Jun 8, 2004

Feb 14, 2002

10/076261

Richard S. Keirsbilck - Rochester NY
Richard N. Blazey - Penfield NY
Peter A. Parks - Topeka KS
David L. Patton - Webster NY
Paige Miller - Rochester NY

The McLean Hospital Corporation - Belmont MA

A61B 500

600549, 600300, 128898

A method of determining threshold values, subsequently used to determine whether an individual has Attention Deficit Hyperactivity Disorder (ADHD) comprising: providing a group of subjects, a segment of which is known to have ADHD and a segment is known to not have ADHD; and testing each subject in the group by: (a) sampling the peripheral skin temperature of left and right like extremities during a predetermined time interval when the subject is in a sensory deprived state to provide respective left and right sampled peripheral skin temperature data; (b) processing the sampled peripheral skin temperature data, including filtering, differentiation, and conversion to the frequency domain to derive spectral signatures having magnitude values; and (c) final processing of spectral signatures for all of the subjects of the group to determine threshold values which are complimentarily effective for determining whether or not an individual has ADHD when tested by the testing method.

6394963, May 28, 2002

Jun 20, 2000

09/597610

Richard N. Blazey - Penfield NY
Peter A. Parks - Topeka KS
David L. Patton - Webster NY

Eastman Kodak Company - Rochester NY

A61B 500

600549, 600300

A method of determining whether an individual has Attention Deficit Disorder (ADD) comprising: sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data; and analyzing the sampled peripheral skin temperature data for a pre-selected parameter, to determine whether said pre-selected parameter has a value indicative of ADD.

6482165, Nov 19, 2002

Oct 19, 2000

09/692682

David L. Patton - Webster NY
Richard N. Blazey - Penfield NY
Peter A. Parks - Topeka KS

Eastman Kodak Company - Rochester NY

A61B 500

600549, 600300

A kit and method for determining whether an individual has Attention Deficit Hyperactivity Disorder, comprising a device for sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state, and an analyzer for analyzing the sampled peripheral skin temperature data for a pre-selected parameter, to determine whether the pre-selected parameter has a value indicative of ADHD.

6565518, May 20, 2003

May 25, 2001

09/865902

Richard N. Blazey - Penfield NY
Peter A. Parks - Topeka KS
David L. Patton - Webster NY
Paige Miller - Rochester NY

Eastman Kodak Company - Rochester NY

A61B 500

600549, 600544, 600546

A method for determining a threshold value of a parameter used to determine whether an individual has Attention Deficit Hyperactivity Disorder (ADHD). The method includes: providing a group of individuals a segment of which is known to have ADHD and a segment of which is known to be normal and not have ADHD; testing each individual in the group by sampling the peripheral skin temperature of the individual during a pre-determined time interval when the individual is in an inactive state to provide sampled peripheral skin temperature data, and analyzing the sampled peripheral skin data to produce a parameter value for that individual. The method further includes: processing the individual parameter values for all of the members of the group to determine a threshold parameter value which is acceptable for determining whether or not an individual has ADHD when tested by the testing procedure.

7037260, May 2, 2006

Apr 27, 2004

10/832824

Richard S. Keirsbilck - Rochester NY, US
Peter A. Parks - Topeka KS, US
David L. Patton - Webster NY, US
Richard N. Blazey - Penfield NY, US
Paige Miller - Rochester NY, US

McLean Hospital Corporation - Belmont MA

A61B 5/00

600300, 600549

A method for determining the appropriate dosage of a medication to treat Attention Deficit Hyperactivity Disorder (ADHD) in an individual who has ADHD. The method comprises sampling the peripheral skin temperature of left and right like extremities of an individual during a predetermined time interval when the individual is in a sensory deprived state to provide respective left and right sampled peripheral skin temperature data, processing the sampled peripheral skin temperature data; processing the sampled peripheral skin temperature data including filtering, differentiation, and conversion to the frequency domain to derive spectral signatures whose magnitudes are indicative of the level of ADHD manifestation. The effectiveness of the medication is calculated by comparison to predetermined threshold values.

6309342, Oct 30, 2001

Oct 29, 1999

9/430445

Richard N. Blazey - Penfield NY
Paige Miller - Rochester NY
Elena A. Fedorovskaya - Pittsford NY
Girish V. Prabhu - Fairport NY
Peter A. Parks - Topeka KS
David L. Patton - Webster NY
John R. Fredlund - Rochester NY
Cecelia M. Horwitz - Penfield NY
Jose M. Mir - Rochester NY

Eastman Kodak Company - Rochester NY

A61M 2100

600 26

A method of determining the physiological reactivity of an individual with respect to images, comprising: measuring at least one physiological parameter of an individual during a baseline calm period of time; measuring the said at least one physiological parameter of said individual during a stress period of time and a succeeding rest period of time; dividing said measured data for each of said periods of time into a plurality of predetermined time segments; computing a histogram or Fourier analysis as appropriate on said predetermined time segments for each said period of time; standardizing said computed data; conducting a principal component analysis, a canonical discriminant analysis, or a neural network, on said data to establish a baseline calm or rest period set of scores and a stress period set of scores; measuring the said at least one physiological parameter of said individual during an image presentation period of time; repeating said time segmenting, said histogram or Fourier analysis, and said standardizing steps on said measured physiological data for said image presentation period of time; applying said vectors from said conducting step to said image data to produce an image set of scores which are compared with said baseline and stress sets of scores; and determining whether said presented image is activating, deactivating, or neutral based on said comparison.

6293904, Sep 25, 2001

Oct 29, 1999

9/429975

Richard N. Blazey - Penfield NY
Paige Miller - Rochester NY
Elena A. Fedorovskaya - Pittsford NY
Girish V. Prabhu - Fairport NY
Peter A. Parks - Topeka KS
David L. Patton - Webster NY
John R. Fredlund - Rochester NY
Cecelia M. Horwitz - Penfield NY
Jose M. Mir - Rochester NY

Eastman Kodak Company - Rochester NY

A61M 2100

600 26

A method of generating a personal image profile based on an individual's physiological and cognitive state compromising: presenting a master set of images to an individual wherein each image in the master set is characterized by a set of scene and image related classifiers that are relevant to producing an effect on an individual; measuring and recording one or more of said individual's physiological parameters while viewing a presented image; measuring the individual's cognitive state from cognitive responses to each presented image; and generating a personal image profile of the individual based on combining the physiological and cognitive measures from said measuring steps, said personal image profile including image classifiers for identifying activating or deactivating images for said individuals.